Dr. Mauro Javier Oruezábal Moreno

Consultant Physician in Medical Oncology at University Hospital of Toledo, Toledo, Spain

Country

Spain

Speciality

Oncology

Subspeciality

Medical Oncology and Genetic Counseling in Oncology

Experience

1994 years

Languages

English, Spanish

Areas of expertise

Medical Oncology
Genetic Counseling in Oncology
Lung Cancer
Breast Cancer
Ovarian Cancer

About the expert

Dr. Mauro Javier Oruezábal Moreno is a respected Consultant Medical Oncologist and Cancer Genetic Counselor with vast expertise in Medical Oncology, Genetic Counseling in Cancer, and research. Based in the University Hospital of Toledo, Spain, he is actively involved in clinical trials for breast, lung, and ovarian cancers. Dr. Oruezábal Moreno has received recognition for his contributions, including the II MAFID Awards, and has a strong commitment to advancing cancer care and research excellence.

Dr. Mauro Javier Oruezábal Moreno is a distinguished Consultant Medical Oncologist and Cancer Genetic Counselor with extensive experience and expertise in the field. Currently serving at the University Hospital of Toledo, Spain, he has held key positions in both clinical practice and academia at reputable institutions, including the Rey Juan Carlos University Hospital in Madrid. Dr. Oruezábal Moreno is a specialist physician in Medical Oncology and a certified Genetic Counselor in Cancer, demonstrating his commitment to providing comprehensive care and counseling to patients.

In addition to his clinical roles, Dr. Oruezábal Moreno is actively involved in research and academia. He has conducted significant research in areas such as the evaluation of chemotherapy response using Positron Emission Tomography (PET) and the management of cancer pain. Furthermore, his expertise extends to bioinformatics and biostatistics, as well as genetic analysis related to cancer pathogenicity research.

Apart from his research endeavors, Dr. Oruezábal Moreno has showcased his leadership by directing the Master's Degree in Oncology at CEU Cardenal Cisneros University and engaging in various clinical trials related to breast, lung, and ovarian cancers. His participation in these trials reflects his dedication to advancing knowledge in oncology and exploring innovative treatment options.

Recognized for his contributions to the field, Dr. Oruezábal Moreno has received several awards and honors, including the II MAFID Awards for his significant contributions to training, research, and teaching in the medical community. His fellowship at the Genetic Department and Cancer Research UK at Southampton University Hospital underscores his commitment to excellence in cancer research and patient care.

Consultant Medical Oncologist
2005 - Today
University Hospital of Toledo, Toledo, Spain
Director of the Master's Degree in Oncology
2016 - Today
CEU Cardenal Cisneros University
Associate Professor of Oncology and Hematology
2012 - 2021
Rey Juan Carlos University
Medical Manager
2021 - 2023
Pivotal CRO
Head of the Oncology Service
2012 - 2021
The ReyJuan Carlos University Hospital (Madrid)
Visiting researcher at the Department of Genetics
2016 - 2018
Cancer Research UK, Southampton University
Head of the Oncology Service
2008 - 2012
University Hospital of Parla, Madrid, Spain
Head of the Oncology Service
2000 - 2008
General Hospital of Alcázar de San Juan, Ciudad Real, Spain

Medical Specialist in Medical Oncology

College of Physicians and Surgeons of Spain

2000
Expert in Bioinformatics and Biostatistics

The Open University of Catalonia

2018
Specialist in Genetic Counseling in Cancer

College of Physicians and Surgeons of Spain

2016
Expert in Bioinformatics

Pablo Olavide University of Seville

2015
Master's Degree in Clinical Management in Oncology

UPF Barcelona School

2015
Master in Palliative Medicine

2004
Doctorate in Medicine with Outstanding Qualification Cum Laude

Universidad Complutense de Madrid

2002
Degree in Medicine and Surgery

University of Navarra

1994

Other experts inthe same specialty

Doctor Premini Mahendra

Consultant Haemato-Oncologist, Birmingham, United Kingdom